Silencing RORγt in Human CD4+ T cells with CD30 aptamer-RORγt shRNA Chimera
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Silencing RORγt in Human CD4+ T cells with CD30 aptamer-RORγt shRNA Chimera
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-17
DOI
10.1038/s41598-019-46855-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of novel quinazolinedione derivatives as RORγt inverse agonist
- (2018) Yoshiyuki Fukase et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structure-based Design and Synthesis of Fluorene Derivatives as Novel RORγ t Inverse Agonists
- (2018) Moustafa T. Gabr et al. CHEMISTRY & BIODIVERSITY
- Discovery of carbazole carboxamides as novel RORγt inverse agonists
- (2018) Yafei Huang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Ixekizumab for the treatment of psoriasis: an update on new data since first approval
- (2018) Christoffer Blegvad et al. Expert Review of Clinical Immunology
- Meta-analysis of the Efficacy and Safety of Secukinumab for the Treatment of Plaque Psoriasis
- (2016) Ju Yeon Ryoo et al. ANNALS OF PHARMACOTHERAPY
- Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease
- (2016) René Pfeifle et al. NATURE IMMUNOLOGY
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- The IL-23–IL-17 axis in inflammatory arthritis
- (2015) Erik Lubberts Nature Reviews Rheumatology
- CD4 aptamer–RORγt shRNA chimera inhibits IL-17 synthesis by human CD4+ T cells
- (2014) Pingfang Song et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms
- (2014) Sheng Xiao et al. IMMUNITY
- Pharmacologic Inhibition of ROR t Regulates Th17 Signature Gene Expression and Suppresses Cutaneous Inflammation In Vivo
- (2014) J. Skepner et al. JOURNAL OF IMMUNOLOGY
- Targeting Th17 cells in autoimmune diseases
- (2014) Jianfei Yang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors
- (2014) Mark C. Genovese et al. Arthritis & Rheumatology
- Pharmacologic Repression of Retinoic Acid Receptor-Related Orphan Nuclear Receptor γ Is Therapeutic in the Collagen-Induced Arthritis Experimental Model
- (2013) Mi Ra Chang et al. Arthritis & Rheumatology
- Identification of SR2211: A Potent Synthetic RORγ-Selective Modulator
- (2012) Naresh Kumar et al. ACS Chemical Biology
- Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Targeting IL-17 and TH17 cells in chronic inflammation
- (2012) Pierre Miossec et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of Potent and Selective Diphenylpropanamide RORγ Inhibitors
- (2012) Jun R. Huh et al. ACS Medicinal Chemistry Letters
- Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of RORγt Protein
- (2011) Tao Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Basis of Digoxin That Antagonizes RORγt Receptor Activity and Suppresses Th17 Cell Differentiation and Interleukin (IL)-17 Production
- (2011) Saori Fujita-Sato et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras
- (2011) Lee Adam Wheeler et al. JOURNAL OF CLINICAL INVESTIGATION
- Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity
- (2011) Jun R. Huh et al. NATURE
- Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand
- (2011) Laura A. Solt et al. NATURE
- CD30 Ligand/CD30 Plays a Critical Role in Th17 Differentiation in Mice
- (2010) X. Sun et al. JOURNAL OF IMMUNOLOGY
- CD30 Ligand Is a Target for a Novel Biological Therapy against Colitis Associated with Th17 Responses
- (2010) X. Sun et al. JOURNAL OF IMMUNOLOGY
- RORC2 Is Involved in T Cell Polarization through Interaction with the FOXP3 Promoter
- (2010) S. Burgler et al. JOURNAL OF IMMUNOLOGY
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells
- (2009) Peng Zhang et al. LABORATORY INVESTIGATION
- The Benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] Is a Novel Retinoic Acid Receptor-Related Orphan Receptor- / Inverse Agonist
- (2009) N. Kumar et al. MOLECULAR PHARMACOLOGY
- Novel Dual Inhibitory Function Aptamer–siRNA Delivery System for HIV-1 Therapy
- (2008) Jiehua Zhou et al. MOLECULAR THERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started